Latest Breaking News On - Chris brinzeywestwicke - Page 1 : comparemela.com

Replimune Reports Fiscal First Quarter 2024 Financial Results and Provides Corporate Update

Replimune Reports Fiscal First Quarter 2024 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesInquiriesarleen goldenbergreplimuneVelekar peeples dyerChris brinzeywestwickeBristol myers squibbPhilip astley sparkeReplimune group incCompany board of directorsExchange commissionProgram highlights milestonesGlobal regulatory group at baker mckenzieAmerican transplant congressAmerican society of clinical oncologySecurities exchangeBiologics license applicationClinical trial collaboration

Replimune (REPL) Announces Departure of Sander Slootweg from Board

Replimune (REPL) Announces Departure of Sander Slootweg from Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sander slootwegPhilip astley sparkeInquiriesarleen goldenbergreplimuneChris brinzeywestwickeSecurities exchangeReplimune group incExchange commissionReplimune groupLooking statements thisSecurities actSecurities exchange actAnnual reportsQuarterly reportsInquiries chris brinzeywestwicke

Replimune Presents Initial RP1 Data from the ARTACUS Clinical Trial at the 2023 American Transplant Congress (ATC) Meeting

Replimune Presents Initial RP1 Data from the ARTACUS Clinical Trial at the 2023 American Transplant Congress (ATC) Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesMichael migdenChris brinzeywestwickeRobert coffinInquiriesarleen goldenbergreplimuneExchange commissionReplimune group incSecurities exchangeResearch developmentChief researchDevelopment officerReplimune groupLooking statementsthisSecurities actSecurities exchange act

Replimune Presents RP1 Data from the IGNYTE anti-PD1 Failed Melanoma Cohort and RP2 Data in Uveal Melanoma at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Replimune Presents RP1 Data from the IGNYTE anti-PD1 Failed Melanoma Cohort and RP2 Data in Uveal Melanoma at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Arleen goldenbergreplimuneRobert coffinChris brinzeywestwickeReplimune group incBristol myers squibbSecurities exchangeExchange commissionResearch developmentWall streetDevelopment officerTrial cohort evaluatingBristol myersUveal melanomaAbstracts being presentedReplimune groupLooking statementsthis

Replimune To Present at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Replimune To Present at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mccormick placeUnited statesChris brinzeywestwickeAmerican society of clinical oncologyBristol myers squibb companyReplimune group incExchange commissionSecurities exchangeMedia inquirieslissette steeleverge scientific communicationsWall streetClinical oncologyAnnual meetingExhibit hallDevelopmental therapeuticsBristol myers squibbReplimune group